Zepatier: Difference between revisions

Revision as of 19:42, 4 December 2016 view source Megan Harris. (talk \| contribs) 72 edits No edit summary ← Older edit		Revision as of 19:42, 4 December 2016 view source Megan Harris. (talk \| contribs) 72 edits No edit summary Newer edit →
Line 2:		Line 2:

	Zepatier is a combination drug combating genotypes 1 and 4 of chronic hepatitis C viral (HCV) infections in adults.		Zepatier is a combination drug combating genotypes 1 and 4 of chronic hepatitis C viral (HCV) infections in adults.


	== Disease in Humans ==		== Disease in Humans ==

Navigation menu